In the Margins
Concentrated bets on individual stocks raise issues for mutual funds and their investors—a matter highlighted last week at Sequoia Fund, one of the biggest investors in controversial drug maker Valeant Pharmaceuticals International Inc. Placing outsize bets on well-chosen stocks can lead to strong performance, but concentration increases the riskiness of a fund and raises questions about how much is too much. Read the original story from The Wall Street Journal.
Most Read
Edward Boudreau will retire from the Columbia Funds board at the end of this year after serving for two years as independent chairman and 14 years ...
In a detailed opinion released this week, a New York judge has explained why he dismissed an excessive fees case against Calamos Advisors. Judge Edgardo Ramos, ...
Susan Wyderko will retire from her position as president and CEO of Mutual Fund Directors Forum in the fall of 2020. When she steps down next ...
Independent mutual fund directors took home more money in 2018, and the boards on which they sit became slightly more diverse, according to new data published ...